CAPR News

Pomerantz LLP Informs Shareholders of Securities Class Action Against Capricor Therapeutics, Inc. – CAPR

CAPR ALERT: Securities Fraud Class Action Launched Against Capricor Therapeutics, Inc. – September 28, 2026 Deadline

CAPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Capricor Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

September 28, 2026 Deadline: Join Class Action Lawsuit Against Capricor Therapeutics, Inc. (CAPR) – Contact Levi & Korsinsky

Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Shareholders of Capricor Therapeutics, Inc. (CAPR): Protect Your Rights Before September 28, 2026 – Contact Levi & Korsinsky

Pomerantz LLP Informs Shareholders of Class Action Filing Against Capricor Therapeutics, Inc. – CAPR

Securities Class Action Lawsuit Filed Against Capricor Therapeutics, Inc. (CAPR) – Levi & Korsinsky Represents Shareholders

Pomerantz LLP Informs Shareholders of Class Action Filing Against Capricor Therapeutics, Inc. – CAPR

CAPR DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR